gip and glp 1 receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Targeting GLP-1, GIP & GCG
Description
Researchers have found that semaglutide and tirzepatide help reduce cardiovascular disease and prevent sleep apnea
J Diabetes Investig (2015) 6:2019
Tolerability and effectiveness of glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease
Body composition assessment by DEXA, BIA, or comparable methodology, at baseline and during treatment, makes lean mass loss visible
Systematic searches were conducted in PubMed/MEDLINE, Embase, Cochrane Library, Web of Science, and ClinicalTrials.gov from database inception through 31 May 2025
